Cortical epileptic afterdischarges in immature rats are differently influenced by NMDA receptor antagonists

European Journal of Pharmacology

Volumn 516, Issue 1, 2005, Pages 10-17

  Šlamberová, Romana ^a,b   Mareš, Pavel ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

(Rat); Cerebral cortex; Development; Epileptic seizure; NMDA receptor antagonist

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; 2 AMINO 7 PHOSPHONOHEPTANOIC ACID; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

AFTERDISCHARGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN CORTEX; BRAIN DEPTH STIMULATION; CLONIC SEIZURE; CONTROLLED STUDY; DRUG MECHANISM; ELECTRODE; EPILEPTIC DISCHARGE; IMMATURITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORIMOTOR CORTEX;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; ANTICONVULSANTS; DIZOCILPINE MALEATE; ELECTRIC STIMULATION; EPILEPSY; EXCITATORY AMINO ACID ANTAGONISTS; INJECTIONS, INTRAPERITONEAL; MOTOR CORTEX; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; TIME FACTORS;

EID: 20344384991     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.04.023     Document Type: Article

References (51)

1. H. Armstrong, L. Zhou, R. Layer, J. Nielson, R.T. McCabe, and H.S. White Anticonvulsant profile of Conantokin G: a novel, broad-spectrum NMDA antagonist Epilepsia 36 1998 39
2. G. Avanzini, M. de Curtis, C. Marescaux, F. Panzica, R. Spreafico, and M. Vergnes Role of the thalamic reticular nucleus in the generation of rhythmic thalamo-cortical activities subserving spike and waves J. Neural Transm., Suppl. 35 1992 85 95
3. M.E. Barton, and H.S. White The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on kindling acquisition and expression Epilepsy Res. 59 2004 1 12
4. R.A. Browning, and D.K. Nelson Modification of electroshock and pentylenetetrazol seizure patterns in rats after precollicular transections Exp. Neurol. 93 1986 546 556
5. A.G. Chapman Excitatory amino acid antagonists and therapy of epilepsy B.S. Meldrum Excitatory Amino Acid Antagonists 1991 Blackwell Scientific Publications London 265 286
6. R.P. Compton, W.F. Hood, and J.B. Monahan Determination of the pharmacokinetics of 2-amino-7-phosphonoheptanoate in rat plasma and cerebrospinal fluid Neurosci. Lett. 84 1988 339 344
7. M.J. Croucher, J.F. Collins, and B.S. Meldrum Anticonvulsant action of excitatory amino acid antagonists Science 216 1982 899 901
8. S.J. Czuczwar, and B.S. Meldrum Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acid Eur. J. Pharmacol. 83 1982 335 338
9. S.J. Czuczwar, H.-H. Frey, and W. Löscher Antagonism of N-methyl-d-aspartic acid-induced convulsions by antiepileptic drugs and other agents Eur. J. Pharmacol. 108 1985 273 280
10. O.E. Della Paschoa, A. Hoogerkamp, P.M. Edelbroek, R.A. Voskuyl, and M. Danhof Pharmacokinetic-pharmacodynamic correlation of lamotrigine, flunarizine, loreclezole, CGP40116 and CGP39551 in the cortical stimulation model Epilepsy Res. 40 2000 41 52
11. J. Davies, A.A. Francis, A.W. Jones, and J.C. Watkins 2-Amino-5-phosphonovalerate (2APV), a potent and selective antagonist of amino acid-induced and synaptic excitation Neurosci. Lett. 21 1981 77 81
12. R. Dingledine, C.J. McBain, and J.O. McNamara Excitatory amino acid receptors in epilepsy Trends Pharmacol. Sci. 11 1990 334 338
13. G.E. Fagg, and L. Massieu Excitatory amino acid receptor subtypes B.S. Meldrum Excitatory Amino Acid Antagonists 1991 Blackwell Scientific Publications London 39 63
14. S. Franceschetti, S. Buzio, G. Sancini, F. Panzica, and G. Avanzini Expression of intrinsic bursting properties in neurons of maturing sensorimotor cortex Neurosci. Lett. 162 1993 25 28
15. B. Hamon, and U. Heinemann Developmental changes in neuronal sensitivity to excitatory amino acids in area CA1 of the rat hippocampus Dev. Brain Res. 38 1988 286 290
16. P.M. Headley, and S. Grillner Excitatory amino acids and synaptic transmission: the evidence for a physiological function Trends Pharmacol. Sci. 11 1990 205 211
17. T.R. Insel, L.P. Miller, and R.E. Gelhard The ontogeny of excitatory amino acid receptors in rat forebrain: I. N-Methyl-d-aspartate and quisqualate receptors Neuroscience 35 1990 31 43
18. C. Koerner, L. Danober, A. Boehrer, C. Marescaux, and M. Vergnes Thalamic NMDA transmission in a genetic model of absence epilepsy in rats Epilepsy Res. 25 1996 11 19
19. E. Krupp, and W. Löscher Anticonvulsant drug effects in the direct cortical ramp-stimulation model in rats: comparison with conventional seizure models J. Pharmacol. Exp. Ther. 285 1998 1137 1149
20. H. Kubová, and P. Mareš Suppression of cortical epileptic afterdischarges by ketamine is not stable during ontogenesis in rats Pharmacol. Biochem. Behav. 52 1995 489 492
21. H. Kubová, P. Mareš, and J. Vorlíček Stable anticonvulsant action of benzodiazepines during development in rats J. Pharm. Pharmacol. 45 1993 807 810
22. D. Lodge, N.A. Anis, and N.R. Burton Effects of optical isomers of ketamine on excitation of cat and rat spinal neurones by amino acids and acetylcholine Neurosci. Lett. 29 1982 281 286
23. P. Mareš, and L. Velíšek N-Methyl-d-aspartate (NMDA)-induced seizures in developing rats Dev. Brain Res. 65 1992 185 189
24. P. Mareš, D. Marešová, S. Trojan, and J. Fischer Ontogenetic development of rhythmic thalamo-cortical phenomena in the rat Brain Res. Bull. 8 1982 765 769
25. P. Mareš, V. Makal, and L. Velíšek Increased epileptogenesis in the immature brain Epilepsy Res., Suppl. 9 1992 127 130
26. P. Mareš, R. Haugvicová, and H. Kubová Unequal development of thresholds for various phenomena induced by cortical stimulation in rats Epilepsy Res. 49 2002 35 43
27. P. Mareš, J. Folbergrová, and H. Kubová Excitatory aminoacids and epileptic seizures in immature brain Physiol. Res. 53 Suppl. 1 2004 S115 S124
28. J.W. McDonald, F.S. Silverstein, and M.V. Johnston Neurotoxicity of N-methyl-d-aspartate is markedly enhanced in developing rat central nervous system Brain Res. 459 1988 200 203
29. A. Mikulecká, and P. Mareš NMDA receptor antagonists impair motor performance in immature rats Psychopharmacology 162 2002 364 372
30. J.-L. Moreau, L. Pieri, and B. Prud'hon Convulsions induced by centrally administered NMDA in mice: effects of NMDA antagonists, benzodiazepines, minor tranquilizers and anticonvulsants Br. J. Pharmacol. 98 1989 1050 1054
31. 3H] MK-801 binding sites in neonate rat brain Brain Res. 487 1989 376 379
32. S.S. Nikam, and L.T. Meltzer NR2B selective NMDA receptor antagonists Curr. Pharm. Des. 8 2002 845 855
33. C.G. Parsons, G. Quack, I. Bresink, L. Baran, E. Przegalinski, W. Kostowski, P. Krzascik, S. Hartmann, and W. Danysz Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo Neuropharmacology 34 1995 1239 1258
34. B.W. Peeters, G.M. Ramakers, B.A. Ellenbroek, J.M. Vossen, and A.M. Coenen Interactions between NMDA and nonNMDA receptors in nonconvulsive epilepsy in the WAG/Rij inbred strain Brain Res. Bull. 33 1994 715 718
35. C. Portera-Cailliau, D.L. Price, and L.J. Martin N-Methyl-d-aspartate receptor proteins NR2A and NR2B are differently distributed in the developing rat central nervous system as revealed by subunit-specific antibodies J. Neurochem. 66 1996 692 700
36. D.A. Prince, and M.J. Gutnick Neuronal activities in epileptogenic foci of immature cortex Brain Res. 45 1972 455 468
37. R.J. Racine Modification of seizure activity by electrical stimulation: II. Motor seizures Electroencephalogr. Clin. Neurophysiol. 32 1972 269 279
38. R. Racine Kindling: the first decade Neurosurgery 3 1978 234 252
39. N.R. Saunders Ontogenetic development of brain barrier mechanisms M.W.B. Bradbury Handbook of Experimental Pharmacology. Physiology and Pharmacology of the Blood-Brain Barrier 1992 Springer Verlag Berlin 327 369
40. D. Schoepp, A.Y. Gamble, C.R. Salhoff, B.G. Johnson, and P.L. Ornstein Excitatory amino acid-induced convulsions in neonatal rats mediated by distinct receptor subtypes Eur. J. Pharmacol. 182 1990 421 427
41. R. Schwarcz Y. Ben-Ari Excitatory Amino Acids and Epilepsy 1986 Plenum Press New York
42. M. Sheng, J. Cummings, L.A. Roldan, Y.N. Jan, and J.Y. Jan Changing subunit composition of heteromeric NMDA receptors during development of rat cortex Nature 368 1994 144 147
43. D.J. Smith, A.J. Azzaro, S.B. Zaldivar, S. Palmer, and H. Lee Properties of optical isomers and metabolites of ketamine in the high affinity transport and catabolism of catecholamines Neuropharmacology 20 1981 391 396
44. O.C. Snead III Basic mechanisms of generalized absence seizures Ann. Neurol. 37 1995 146 157
45. M. Steriade, and M. Deschenes The thalamus as a neuronal oscillator Brains Res. Rev. 8 1984 1 62
46. L. Velíšek, R. Mikolášová, S. Blanková-Vaňková, and P. Mareš Effects of ketamine on metrazol-induced seizures during ontogenesis in rats Pharmacol. Biochem. Behav. 32 1989 405 410
47. R.A. Voskuyl, J. Dingmanse, and M. Danhof Determination of the threshold for convulsions by direct cortical stimulation Epilepsy Res. 3 1989 120 129
48. R.A. Voskuyl, A. Hoogerkamp, and M. Danhof Properties of the convulsive threshold determined by direct cortical stimulation in rats Epilepsy Res. 12 1992 111 120
49. A. Wenzel, J.M. Fritschy, H. Mohler, and D. Benke NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins J. Neurochem. 68 1997 469 478
50. E.H. Wong, J.A. Kemp, T. Priestley, A.R. Knight, G.N. Woodruff, and L.L. Iversen The anticonvulsant MK-801 is a potent N-methyl-d-aspartate antagonist Proc. Natl. Acad. Sci. U. S. A. 83 1986 7104 7108
51. W. Yen, J. Williamson, E.H. Bertram, and J. Kapur A comparison of three NMDA receptor antagonists in the treatment of prolonged status epilepticus Epilepsy Res. 59 2004 43 50